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IntroductIon
Kidney transplantation is the treat-
ment of choice for most patients on 
dialysis.1 However, literature re-
ports have described an overall sur-
gical mortality rate of 1% to 4% for 
patients with chronic kidney disease 
(CKD). This rate is even higher in 
elderly and diabetic patients and 
may be five times higher in emer-
gency settings.2,3
Deceased donor kidney trans-
plants are carried out in emergency 
conditions. The candidate with the 
best HLA compatibility is known 
hours before the start of surgery. 
Additionally, the risk of preopera-
tive morbidity and mortality in this 
population is high, given that besi-
des CKD, they are often afflicted by 
other morbidities. The summation 
of perioperative risk and the risks 
associated with immunosuppressive 
therapy have resulted in a risk of 
death nearly three times higher 
when compared to patients kept on 
dialysis for the first two weeks after 
transplantation.1
Scoring systems and scales have 
been widely applied in different medical 
fields to estimate the probability of an 
outcome in quantitative terms.4-8 In renal 
transplantation, several mathematical 
models have been published with the 
purpose of predicting survival and renal 
function following transplantation. 
However, the cumbersomeness often 
present in these models, the need to 
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Introduction: Kidney transplantation is 
performed in emergency conditions in a 
population with high perioperative risk. In-
struments for risk assessment before trans-
plantation in this population are scarce. 
Objective: To develop a score with pretrans-
plant variables to estimate the probability of 
success of kidney transplantation, defined 
as survival of the recipient and the graft 
with creatinine ≤ 1.5 mg/dl at 6 months. 
Methods: Analysis of variables of patients 
from a unique kidney transplantation center 
in São Paulo. Logistic regression was used to 
construct an equation with variables able to 
estimate the probability of success. Integer 
points were assigned to variables for score 
construction. Results: Of the 305 patients 
analyzed, 176 (57.7%) achieved success. 
Of the 23 variables identified by univariate 
analysis, 21 were included in the logistic re-
gression model and 10 that remained inde-
pendently associated with success, were used 
in the score. Four of these 10 variables were 
socioeconomic. It was great (area under the 
ROC curve 0.817) the power of discrimina-
tion between groups success and not success 
and adequate (Hosmer and Lemeshow = 
0.672) the agreement between frequencies of 
the probabilities estimated by equation and 
frequencies of probabilities actual observed. 
There were correlation (0.982) between the 
estimated probability via the scoring system 
and the estimated probabilities via logistic 
regression. Conclusion: Point score simpli-
fied risk stratification of transplant candi-
date according to their probability of suc-
cess. Socioeconomic variables influence the 
success, demonstrating the need for creation 
of prognostic tools utilizing clinical and de-
mographic variables of our population.
AbstrAct
Keywords: kidney transplantation; measures 
of association; exposure; risk; outcome; 
odds ratio; risk factors.
DOI: 10.5935/0101-2800.20140049
J Bras Nefrol 2014;36(3):339-351
Risk assessment
340
perform complex calculations, and the lack of 
information at the time of patient assessment have 
hindered a more widespread use of these tools in 
transplant centers. van Walraven et al.9 published 
a scale to estimate the five-year risk of death of 
patients on dialysis for renal transplantation. The 
author used a statistical methodology similar to 
ours to assign integer scores to the relative risks 
of 12 demographic variables associated with 
outcome. However, such a system requires the use 
of accurate data on patient total time on a waiting 
list, time until listed for transplant, serum albumin, 
and eight comorbidities, which may hamper the 
application of the scale. Scales were also designed 
to quantify the risk of graft loss based on different 
donor characteristics.10 Nyberg et al.11 proposed 
a scale to identify renal grafts from deceased 
donors associated with high risk of early renal 
dysfunction. However, the arbitrary stratification 
of risk categories may have contributed to this 
scale’s reduced accuracy.
Various cohort studies have identified 
pre-transplant recipient and donor variables asso-
ciated with different transplant outcomes,12-15 in 
addition to the significant impact of sociocultural 
and economic variables upon outcomes.16-18
Socioeconomic variables have been 
reported to influence health-related outcomes 
in Brazil. However, despite the socioeconomic 
disparities between the country’s 26 states 
and five regions, the Brazilian transplant 
program has established itself as one of the 
largest in the world, allowing broad access 
to renal therapies.19 In 2012, 5,385 of the 
7,426 organ transplants performed in Brazil 
were kidney transplants.20 However, not 
much has been published in the literature 
about the correlation between socioeconomic 
variables and post-transplant outcomes in 
Brazil. Studies have been carried out in a 
few centers in the country, and virtually 
all of them covered patients treated in the 
Southeast (80%) and South (16%) regions. 
In 2009, over 80% of the transplants done 
in Brazil were performed in the Southeast 
and South regions. In 2007, the states of São 
Paulo, Santa Catarina and Rio Grande do Sul 
had over 10 donors per million population, 
whereas in the Northern Brazilian states no 
organs were procured from deceased donors. 
Thus, despite the existence of a well-organized 
national transplant system and the increasing 
number of kidney transplants, differences 
in the number of transplants still persist as 
a reflex of the socioeconomic and cultural 
disparities seen between the regions of the 
country.21
Kidney function six months after transplant 
has been described as an independent risk 
factor associated with graft loss 24 months 
after transplantation in our patient popula-
tion.22 A retrospective study using data from 
the UNOS/OPTN enrolled 105,742 kidney 
transplant patients confirmed this finding and 
showed that poor renal function, estimated 
by serum creatinine levels > 1.5 mg/dL six and 
12 months after transplantation, was correla-
ted with decreased long-term graft survival.23
The estimated probability of having a suc-
cessful kidney transplant using an intermediate 
endpoint such as renal function six months 
after transplant and selected variables of the 
Brazilian population may add value to patient 
counseling. Thus, the goal of this study was 
to develop a risk assessment scale considering 
pre-transplant recipient and donor variables to 
estimate the probability of success of kidney 
transplant procedures.
MAterIAls And Methods
DefinitiOn Of SucceSS
Patients with functional grafts and creatinine 
levels lower than or equal to 1.5 mg/dl six months 
after transplantation were deemed to have been 
successfully treated.
StuDy DeSign
This prospective cohort study enrolled deceased 
donor renal transplant patients seen between 
February and November of 2011. Subjects had to 
be 18 or older to be enrolled in the study. Multiple 
organ transplant patients were excluded. The 
selected patients were interviewed on the day of 
transplantation. Medical and demographic data 
were obtained from their charts. Patients were 
not required to give informed consent. The study 
protocol was approved by the UNIFESP Research 
Ethics Committee (Nº 1139/10).
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StatiStical analySiS
Sixty pre-transplant variables were selected and 
divided into seven categories: demographics, co-
morbidities, socioeconomic variables, workup, 
quality of life, donors, and medication (Chart 1).
Univariate analysis was performed for 
the 60 risk variables between the two study 
groups to identify the ones associated with 
success with a statistical significance level of 
10%. Categorical variables were treated with 
the chi-square or Fisher’s exact test. Numeric 
variables were analyzed using Student’s t test 
for independent samples.
Multivariate analySiS
Logistic regression analysis was used to identify 
pre-transplant variables independently associated 
with successful treatment. Initially, all variables 
associated with successful transplantation with 
a significance level of 10% were included in the 
logistic model. Then, the non-significant variables 
at a 5% significance level were excluded in the 
final calculation. Data was included based on or-
der of magnitude as defined in forward stepwise 
regression.
The logistic regression equation for the 
studied population had ß coefficients for each of 
Demographic variables Comorbidities
Age Degree of dependence
Gender Hypertension
Ethnicity Diabetes
Renal disease etiology Dyslipidemia
Time with kidney disease Prior cardiovascular event
Mode of dialysis Nutritional status
Time on dialysis Peripheral vascular disease
Retransplant Psychiatric disease
Prioritization Hepatitis B, C, CMV
Panel reactive antibody HIV
A, B, DR Mismatches Drinking
Smoking
Socioeconomic variables Workup
Level of education Abdominal waist
Patient monthly income Weight (kg)
Household monthly income Residual kidney function
Public aid/welfare Peripheral pulses
Living conditions Physical disability
Economic activity Dental health
Time on leave from work ECG
Quality of life Donor variables
Patient impressions over his/her health Age
Personal leve of satisfaction Gender
Depression/Exhaustion Weight (kg)
Performance of daily living activities requiring mild/moderate/
intense effort
Creatinine
Spouse Etiology of death
Family support Hypertension
Children Medication
Assistance to take medication Medication in use
Number of medications
Knowledge of medications
chArt 1 Sixty pre-tranSplant variableS
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the risk variables identified in the logistic model. 
The exponential ß coefficients [exp (ß)] were 
interpreted as odds ratio (OR). This equation 
allowed the calculation of the probability of 
successful transplantation as an exponential 
function of the risk variables for any set of 
characteristics of a given individual.
The Hosmer-Lemeshow test was used to assess 
the degree of agreement of the equation when 
comparing the frequencies of the probabilities 
estimated by the equation and the observed fre-
quencies of the probabilities. The area under the 
ROC curve was used to assess the ability of the 
equation to discriminate between success and 
non-success.
the Scale
The method described by Sullivan19 was used to 
build a scale using the variables identified by logis-
tic regression analysis. Seven statistical adjustment 
steps were taken to allow the conversion of units 
of measurement between the two systems (logistic 
regression units into score units) while preserving 
the degree of association of each risk variable in 
estimating the probability of transplant success.
Step 1: the ß regression coefficients for 
variables associated with success transplantation 
were obtained (ß0, ß1,….., ßx). Step 2: variable 
values were stratified to create subcategories and 
determine the reference values for these subcate-
gories (ɯij i = number of risk variables, j = total 
number of subcategories for i risk variables). 
Step 3: variable subcategories of reference were 
obtained (ɯref). Step 4: the distance in regression 
units between the other subcategories in relation 
to the subcategory of reference [ßi (ɯij - ɯref)]. 
Step 5: a constant (ʗ) was defined for the system 
(number of logistic regression units correspon-
ding to 1 point in the scoring system). Step 6: the 
number of points in each variable subcategory 
was calculated using the system’s ß coefficient 
and constant ʗ [Pointsij = ßi (ɯij - ɯref)/ʗ]. Step 
7: the possible scores were multiplied by ʗ and, 
through statistical adjustments, the probabilities 
of success were obtained.
The intraclass correlation coefficient was used 
to quantify the degree of agreement between the 
estimated probabilities obtained via logistic regres-
sion and via the scoring system for each individual.
A significance level of 5% was used in all sta-
tistical tests. Software package SPSS 17.0 was 
used in statistical analysis.
results
Six of the 311 enrolled patients were lost in follow-
-up by six months of transplantation. One hundred 
and seventy-six were deemed to have been succes-
sfully transplanted. Thirteen of the unsuccessful 
cases died, 15 suffered from graft failure, and 101 
had serum creatinine levels > 1.5 mg/dL (Figure 1).
Figure 1. Algorithm for the studied population.
Patients had a mean age of 47.5 years; most we-
re males (60.7%), Caucasian (47.9%), had CKD 
of unknown etiology (37%), underwent kidney 
transplantation for the first time (94.8%), and 
were treated through the Brazilian Public Heath 
Care System (87.3%). Before transplantation, 
most patients had been on hemodialysis (88.2%) 
for a mean of 4.3 years (Table 1).
The descriptive and frequency analysis findin-
gs of the 60 pre-transplant variables of the enrol-
led patients were divided into seven categories. 
Univariate analysis revealed that 21 of the 60 
recipient and donor demographic, clinical and 
socioeconomic variables were associated with 
successful procedures. Five of these variables 
were demographic, two were socioeconomic, 
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tAble 1 patient DeMOgraphic variableS
Variable
Total 
(n = 305)
Success 
(n = 176)
Non-sucsess 
(n = 129)
p
Age ± SD (min-máx), years 47.5 ± 12.3 (18-76) 48.6 ± 12.6 (19-76) 46 ± 11.9 (18-68) 0.68
Male gender, n (%) 185 (60.7) 86 (48.9) 99 (76.7) 0.00
Ethnicity, n (%) 0.61
Caucasian 146 (47.9) 87 (49.7) 59 (45.7)
Brown 67 (22.0) 34 (19.3) 33 (25.6)
Black 78 (25.6) 46 (26.1) 32 (24.8)
Asian 14 (4.6) 9 (5.1) 5 (3.9)
Etiology of CKD, n (%) 0.31
Undetermined 113 (37.0) 59 (33.5) 54 (41.9)
Hypertensive nephrosclerosis 31 (10.2) 23 (13.1) 8 (6.20)
Polycystic kidney disease 45 (14.8) 29 (16.5) 16 (12.4)
Diabetic nephropathy 40 (13.1) 22 (12.5) 18 (14.0)
Glomerulonephritis 52 (17.0) 30 (17.0) 22 (17.1)
Others 24 (7.9) 13 (7.4) 11 (8.5)
Hemodialysis, n (%) 269 (88.2) 153 (86.9) 116 (89.9) 0.42
Time on dialysis ± SD (min-máx), years 4.3 ± 3.4 (0-20) 4.2 ± 3.6 (0-20) 4.3 ± 3.1 (0.25-20) 0.89
Time on dialysis, n (%) 0.10
≤ 2 years 109 (35.7) 68 (38.6) 41 (31.8)
2-10 years 174 (57) 92 (52.3) 82 (63.6)
> 10 years 22 (7.2) 16 (9.1) 6 (4.7)
Time on conservative treatment ± SD, years 3.7 ± 6.4 4.5 ± 7.3 2.7 ± 4.8 0.01
Health insurance, n (%) 68 (22,3) 44 (25.0) 24 (18.6) 0.19
First kidney transplant, n (%) 289 (94.8) 164 (93.2) 125 (96.9) 0.15
Prioritized, n (%) 10 (3.3) 7 (4.0) 3 (2.3) 0.53
Panel-reactive antibody ± SD (min-max), % 15.3 ± 26.3 (0-100) 18.1 ± 27.9 (0-99) 11.4 ± 23.5 (0-100) 0.02
Panel ≥ 30%, n (%) 60 (19.7) 44 (25) 16 (12.4) 0.01
Zero HLA-A MM, n (%) 56 (18.4) 35 (19.9) 21 (16.3) 0.42
Zero HLA-B MM, n (%) 69 (22.6) 40 (22.7) 29 (22.5) 0.96
Zero HLA-DR MM, n (%) 238 (78) 145 (82.4) 93 (72.1) 0.03
Zero HLA A, B, DR MM, n (%) 23 (7.5) 16 (9.1) 7 (5.4) 0.80
three were related to quality-of-life, two to 
comorbidity, three to workup, and six were do-
nor variables (Table 2).
The individual impact of these 21 variables 
was analyzed through logistic regression 
analysis, and ten were independently associated 
with outcome of transplantation. Two of these 
ten variables were socioeconomic, two were 
demographic, one was related to comorbidities, 
one to workup, two to quality of life and two 
were donor variables (Table 3).
The β coefficients of the ten variables were used 
to build a logistic regression equation (Figure 2) 
and estimate the transplant probability of success.
The Hosmer-Lemeshow test showed 
no differences between the probability 
frequencies estimated using the equation and 
the frequencies of the observed probabilities 
for the 305 patients (p = 0.672). The area 
under the ROC curve was 0.817, indicating 
that the equation with the ten pre-transplant 
variables had great discriminatory power to 
tell successfully from unsuccessfully treated 
patients.
The scoring system derived from the ten variables 
independently associated with success cases is 
shown on Table 4. The setup of the scale takes 
into account the stratification of categorical and 
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tAble 2 twenty-One variableS aSSOciateD with tranSplant SucceSS in univariate analySiS (p ≤ 0.10)
Variable Success (n = 176) Non-success (n = 129) p
Demographics
Recipient gender, n (%) 0.00
Male 90 (51.1) 30 (23.3)
Female 86 (48.9) 99 (76.7)
Time on dialysis, n (%) 0.09
≤ 2 years 68 (38.6) 41 (31.8)
> 2 years 108 (61.4) 88 (68.2)
Time on conservative treatment ± SD, years 4.5 ± 7.3 2.7 ± 4.8 0.01
Panel reactive antibody, n (%) 0.00
≥ 30% 44 (25) 16 (12.4)
< 30% 132 (75) 113 (87.6)
DR Mismatch, n (%) 0.03
Zero 145 (82.4) 93 (72.1)
Some MM 31 (17.6) 36 (27.9)
Socioeconomic variables
Public aid/welfare, n (%) 0.03
Dependent 112 (63.6) 97 (75.2)
Independent 67 (37.4) 32 (24.8)
Patient monthly income, n (%) R$* 0.00
< 3000,00 134 (76.1) 75 (58.1)
≥ 3000,00 42 (23.9) 54 (41.9)
Quality of life
Children, n (%) 0.00
Yes 150 (85.2) 92 (71.3)
No 26 (14.8) 37 (28.7)
Family support, n (%) 0.02
Yes 148 (84.1) 95 (73.6)
No 28 (15.9) 34 (26.4)
Patient thinks he/she is in GOOD health, n (%) 0.05
Yes 169 (96) 117 (90.7)
No 7 (4) 12 (9.3)
Comorbidities
CMV serology, n (%) 0.01
Positive 6 (3.4) 13 (10.1)
Negative 170 (96.6) 116 (89.9)
Peripheral arterial disease, n (%) 0.09
Present 5 (2.8) 9 (7.0)
Absent 171 (97.2) 120 (93)
Workup
Weight ± SD (min-max), kg 66 ± 12.6 (36-104) 70 ± 14.2 (41-108) 0.00
ECG alterations, n (%) 0.00
Yes 60 (34.1) 69 (53.5)
No 116 (65.9) 60 (46.5)
Physical disability n (%) 0.04
Yes 23 (13.1) 28 (21.7)
No 153 (86.9) 101 (78.3)
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Donor
Donor gender, n (%) 0.05
Male 121 (68.7) 75 (58.1)
Female 55 (31.3) 54 (41.9)
Donor age ± SD (min-max), years 43.9 ± 43.9 (18-74) 50 ± 11.8 (19-74) 0.00
Donor weight ± SD (min-max), kg 75.4 ± 13.6 (45-120) 72.5 ± 14.4 (45-120) 0.08
Donor death etiology, n (%) 0.00
Cardiovascular disease 82 (46.6) 84 (65.1)
Other 94 (53.4) 45 (34.9)
Donor hypertension, n (%) 0.05
Yes 58 (33.0) 57 (44.2)
No 118 (67.0) 72 (55.8)
Expanded criteria donor, n (%) 0.06
Yes 48 (27.3) 48 (37.2)
contInued tAble 2.
* Income of US$ 1,260.00.
tAble 3 ten variableS inDepenDently aSSOciateD with tranSplant SucceSS in the final lOgiStic regreSSiOn MODel
ß coefficient p Odds ratio (OR) 95% Confidence Interval for odds ratio
Recipient gender
Female 0.99 0.004 2.69 1.37-5.30
Male (ref.) 0.00 - 1.00 -
Recipient weight -0.04 0.002 0.96 0.94-0.99
DR Mismatch
Zero 1.34 0.000 3.80 1.88-7.69
Some MM (ref.) 0.00 - 1.00 -
Public aid/welfare
Yes (ref.) 0.00 - 1.00 -
No 0.63 0.045 1.89 1.02-3.52
Patient monthly income
< R$ 3.000 (ref.) 0.00 - 1.00 -
≥ R$ 3.000 1.45 0.004 4.26 1.59-11.39
Children
Yes 1.06 0.004 2.90 1.42-5.93
No (ref.) 0.00 - 1.00 -
Family support
Yes 0.77 0.028 2.17 1.09-4.33
No (ref.) 0.00 - 1.00 -
ECG alterations
Yes (ref.) 0.00 - 1.00 -
No 0.95 0.002 2.59 1.42-4.72
Donor death etiology
Other 0.65 0.030 1.92 1.07-3.48
Cardiovascular disease (ref.) 0.00 - 1.00 -
Donor age -0.04 0.001 0.96 0.94-0.98
Constant 1.05 0.339 2.86 -
J Bras Nefrol 2014;36(3):339-351
Risk assessment
346
Figure 2. Logistic regression equation.
continuous variables into subcategories. A variation 
of five years on donor age in relation to transplant 
probability of success was considered as the ʗ in our 
scale. Therefore, one point in the score corresponded 
to an increase in transplant probability of success 
equivalent to receiving a graft from a kidney donor 
five years younger. Table 5 exemplifies the allocation 
of points for the two profiles of patients with the 
highest and the lowest scores. Scores ranged from 0 
to 56 points. In the studied population, scores ranged 
from eight (probability of success of 1.9%) to 46 
points (probability of success of 98.5%) (Table 6).
The agreement between the probabilities 
estimated with logistic regression and the pro-
babilities calculated via the scale was deemed 
adequate [0.982, 95% CI (0.978 to 0.986)].
dIscussIon
This study proposed a pre-transplant scale with 
10 demographic donor and recipient variables 
to estimate the probability of success of kidney 
transplants. Success was defined as the patient 
being alive six months after transplantation, ha-
ving a functional graft and creatinine levels be-
low or equal to 1.5 mg/dL.
The clinical application of the scale did not 
require the use of statistical software packages 
or calculators. The assignment of integer values 
(points) to the 10 risk variables based on how 
they correlated to patient outcomes combined 
advanced statistical methods and logistic regres-
sion analysis.24
A review published by Kasiske in 2010 
revealed substantial variance in the findings 
reported in 20 studies that used multivariate 
analysis to calculate the risks associated with 
various renal transplant outcomes. The analyzed 
tAble 4 ScOreS
Risk variables Value (ɯ) Coefficient (ß) ßi (ɯ-ɯref)
Score = ßi 
(ɯ-ɯref)/ʗ
Gender 0.992
Female 1 0.99 5
Male (ref.) 0 = ɯref 0.00 0
DR Mismatch 1.336
Zero 1 1.36 6
Some MM (ref.) 0 = ɯref 0.00 0
Public aid/welfare 0.636
Yes (ref.) 0 = ɯref 0.00 0
No 1 0.63 3
Patient monthly income 1.45
< R$ 3000 (ref.) 0 = ɯref 0.00 0
≥ R$ 3000 1 1.44 7
Children 1.07
Yes 1 1.07 5
No (ref.) 0 = ɯref 0.00 0
Family support 0.77
Yes 1 0.77 4
No (ref.) 0 = ɯref 0.00 0
ECG alterations 0.95
Yes (ref.) 0 = ɯref 0.00 0
No 1 0.95 4
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Recipient weight -0.04
≤ 50 43.0 2.07 10
50 ---| 60 55.5 1.57 7
60 ---| 70 65.5 1.17 5
70 ---| 80 75.5 0.76 4
> 80 (ref.) 94.5 = ɯref 0.00 0
Donor cause of death
Other 1 0.65 0.65 3
Cardiovascular disease (ref.) 0 = ɯref 0.00 0
Donor age -0.04
≤ 30 24.0 1.86 9
30 ---|40 35.5 1.37 6
41 ---|50 45.5 0.94 4
51 ---|60 55,5 0.51 2
> 60 (ref.) 67.5 = ɯref 0.00 0
Donor age -0.04
≤ 30 24.0 1.86 9
30 ---|40 35.5 1.37 6
41 ---|50 45.5 0.94 4
51 ---|60 55.5 0.51 2
> 60 (ref.) 67.5 = ɯref 0.00 0
Constant 1.05
contInued tAble 4.
tAble 5 patient ScOreS - iD 200 & iD 70
Variables Scores Profile ID = 200 Profile ID = 70
Female 5 1 0
Zero DR mismatch 6 1 0
No public aid/welfare 3 1 0
Patient income ≥ R$ 3,000.00 7 1 0
Patients with children 5 1 0
Good family support 4 1 0
No ECG alterations 4 1 1
Recipient weight
≤ 50 10 0 0
50 ---| 60 7 0 0
60 ---| 70 5 0 0
70 ---| 80 4 0 1 (74 kg)
> 80 0 1 (84 kg) 0
Other donor causes of death 3 1 0
Donor age
≤ 30 9 1 (20 years) 0
30 ---|40 6 0 0
41 ---|50 4 0 0
51 ---|60 2 0 0
> 60 0 0 1 (66 years)
Total Score 46 8
1 = Yes; 0 = No.
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tAble 6 SucceSS prObabilitieS baSeD On tOtal ScOreS
Score Estimated probability Score Estimated probability
0 0.004 29 0.637
1 0.004 30 0.685
2 0.005 31 0.729
3 0.007 32 0.769
4 0.008 33 0.805
5 0.010 34 0.836
6 0.013 35 0.863
7 0.016 36 0.886
8 0.019 37 0.906
9 0.024 38 0.923
10 0.029 39 0.937
11 0.036 40 0.948
12 0.044 41 0.958
13 0.055 42 0.966
14 0.067 43 0.972
15 0.081 44 0.977
16 0.099 45 0.982
17 0.119 46 0.985
18 0.144 47 0.988
19 0.172 48 0.990
20 0.204 49 0.992
21 0.241 50 0.994
22 0.282 51 0.995
23 0.328 52 0.996
24 0.376 53 0.997
25 0.427 54 0.997
26 0.480 55 0.998
27 0.534 56 0.998
combinations of variables relative to recipient 
and/or donor risks were presented in the form of 
algorithms, scales, and tables.25-29 However, the 
complex mathematical equations described in 
some of these studies have not been used in the 
clinical practice of transplant centers.
van Walraven et al. also used the methodology 
described by Sullivan to build a scale to estimate the 
risk of death within five years for kidney transplant 
candidates on dialysis. The 12 variables used 
referred only to recipients.9 Interestingly, except 
for recipient age, the variables identified by van 
Walraven et al. did not match the ones described in 
our study. Such observation speaks of the specific 
associations held between variables and analyzed 
outcomes. The variables in the scale described by 
van Walraven et al. correlated with the long-term 
survival endpoint analyzed by the author. The ten 
variables considered in our study were associated 
with patient survival and satisfactory renal function 
six months after renal transplantation.
The two donor variables associated with 
transplant success, age and etiology of death, 
were in agreement with previous literature 
reports.30,31 A four percent reduction in the 
chance of transplant success was observed when 
donor age was added by one year starting from 
the age of 30. Moreover, recipients of kidneys 
coming from donors who died of cardiovascular 
disease were 50% less likely to have successful 
transplants than recipients of kidneys from 
donors who died of other causes. Previous reports 
indicate that donor age and cause of death were 
largely responsible for the variability of kidney 
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transplant outcomes, as both have been directly 
related to the quality of the transplanted kidney.32
Weight was the only of the 18 assessed 
comorbidities correlated with transplant outcome. 
A longer follow-up period would be necessary to 
clarify the impact of chronic comorbidities and 
insidious progression of transplant outcomes. This 
study was designed to estimate kidney transplant 
viability, not long-term patient survival. The short 
time for which patients were followed did not 
allow the manifestation of such association.
A noteworthy four of the eight recipient variables 
associated with successful transplantation (public 
aid/welfare, patient monthly income, children, and 
family support) were related to socioeconomic and 
quality-of-life variables. Recipients off welfare had 
twice the chance of success than subjects on wel-
fare. Additionally, patients with monthly incomes 
over R$ 3,000 were four times more likely to have 
successful transplants. Lower socioeconomic sta-
tus has been associated with increased incidence 
of chronic diseases, progression of renal disease, 
inadequate dialysis, reduced chances of having 
access to transplantation, and worse health outco-
mes in general.33 Poorer patients also complied less 
with drug therapy and had worse outcomes after 
transplantation.34
Patients with children were three times 
more likely to have successful transplants than 
childless individuals, and patients supported by 
their families were twice more likely to have 
successful outcomes, indicating that factors 
related to quality of life impacted renal transplant 
outcomes. We assume that patients with children 
belong to more stable families. In previous 
studies, dialysis and transplant patients with 
supportive families, stable marriages, jobs, and 
higher levels of education were more satisfied 
with the course of therapy and had higher mental 
state scores.33,34 These factors are believed to be 
associated with greater compliance to treatment 
and better outcomes in the long run.35,36 Our 
results showed that recipients with lower 
socioeconomic and quality-of-life scores had 
lower chances of having successful transplants. 
These characteristics are not routinely assessed or 
recorded because they are subjective and difficult 
to quantify. However, as shown by our results, 
non-traditional risk factors were associated with 
worse short-term outcomes and had a bigger 
impact than anticipated.
The scale developed in this study performed to 
satisfaction when used in our population. It offered 
good discrimination between patients successfully 
and unsuccessfully transplanted, with an accuracy 
of 81.7%. Additionally, no differences were found 
in the frequencies of estimated and observed 
probabilities of the 305 enrolled patients.
The estimation of probable treatment success 
rates before the start of therapy has been pursued 
in medical practice for many years. However, 
the decision to perform a transplant has been 
grounded on non-quantitative information 
derived from clinical experience and scientific 
knowledge. Despite the proven long-term benefits 
of renal transplantation, the procedure is still 
associated with high perioperative mortality rates.
Death rates during the transition period of dialysis 
and deceased donor kidney transplants (one to three 
months after transplantation) were higher than the 
mortality rate of patients on the transplant waiting 
list (9.57 versus 6.38 deaths/100 patient-years).36 
The rate of perioperative cardiovascular events was 
eight times higher than the relatively constant rates 
reported for patients on dialysis (39.6 versus 5.3 to 
6.6 cardiovascular events/100 patient-years).37 In 
contrast, in Brazil infection still prevails as the main 
cause of death among patients.38 Infectious compli-
cations were observed in 49% of kidney recipients 
in the first year after transplantation and, in addi-
tion to immunosuppressive therapy, factors related 
to socioeconomic conditions, health and hygiene, 
and prior epidemiological exposure to contagious 
diseases contributed to these results.
Studies on the use of scales in routine 
pre-transplant examination are generally scarce, 
and papers considering Brazilian patient popula-
tions are virtually inexistent. The growing interest 
in the development of scales may help determine 
whether new instruments have better prognostic 
accuracy than clinical assessment alone in catego-
rizing patients into different prognostic groups.
However, the implementation of theoretical 
models should always be carefully considered 
and performed with caution, as there is a 
distance between the statistical performance 
of the scale and what it actually delivers. The 
variables considered in this study cannot be 
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used to predict outcomes, as they rely merely on 
a relationship of association. To do so, clinical 
markers must be evaluated for their positive 
predictive value39,40 within a relevant assessment 
context. The validation of the scale discussed in 
this paper is underway in the second stage of this 
study. The objective is to ascertain whether the 
same degree of agreement, discrimination, and 
correlation obtained in this study will be repeated 
for a different cohort of patients. In order for 
this scale to be used in clinical practice, score 
categories might have to be linked to acceptable 
risk levels, thus allowing the quantification 
of pre-transplant risk in a continuous scale, 
differently from what would happen if one single 
cutoff value were defined to decide whether a 
patient should undergo transplantation.
The logistic regression model and the sample of 
the population used to build the scale limit40 its use. 
The scale was developed for a population that is 
not distinguished by any particular characteristic. 
Therefore, its results cannot be extrapolated or 
applied to other specific segments of the population. 
Additionally, the scale can only be used to assess 
recipients of deceased donor kidneys with complete 
information on 10 analyzed variables.
This is the first Brazilian study to use logistic 
regression analysis for the development of a risk 
assessment scale for pre-renal transplant patients. 
We believe that treatment individualization 
requires knowledge of considerably accurate 
quantitative information, and probabilistic 
models may be used to this end.41
conclusIon
The scale with ten demographic donor and recipient 
variables used in this study was able to estimate 
the probability of patients in our population 
having successful renal transplants. Four of the ten 
variables were significantly correlated with impact 
in the socioeconomic category, thus reinforcing the 
need to create prognostic scales that take clinical 
variables of our own population into account.
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